CNS Disorders  >>  azeliragon (TTP488) 
Welcome,         Profile    Billing    Logout  

1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
azeliragon (TTP488) / Cantex Pharma
2017-004065-27: Clinical Study to assess the Safety And Efficacy Of Investigational Medicinal Product Azeliragon (TTP488) In Patients With Mild Alzheimer's Disease who have previously completed a Clinical Trial with Azeliragon (TP488)

Not yet recruiting
3
800
Europe
Azeliragon, TTP488, Capsule, hard
vTv THERAPEUTICS LLC, vTv THERAPEUTICS LLC
MILD ALZHEIMER'S DISEASE, MILD ALZHEIMER'S DISEASE, Diseases [C] - Nervous System Diseases [C10]
 
 

Download Options